Reuters logo
5 个月前
BRIEF-Biondvax says approved for grant from Israel's Ministry of Economy and Industry to build facility for commercial scale production of universal flu vaccine
2017年3月30日 / 早上6点26分 / 5 个月前

BRIEF-Biondvax says approved for grant from Israel's Ministry of Economy and Industry to build facility for commercial scale production of universal flu vaccine

March 30 (Reuters) - Biondvax Pharmaceuticals Ltd

* Biondvax pharmaceuticals - approved for grant from Israel's Ministry of Economy and Industry to build facility for commercial scale production of universal flu vaccine

* Biondvax - plans to build mid-sized factory in Jerusalem, with potential capacity to annually produce up to tens of millions of doses of M-001

* Biondvax - five completed phase 1/2 and phase 2 human clinical trials have shown vaccine to be safe and immunogenic to multiple flu strains Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below